The U.S. Food and Drug Administration (FDA) is seeking a quotation for an Octet RH96 High-throughput BLI plate reader that utilizes Biolayer Interferometry (BLI) to support high-throughput potency assays, antibody titer measurement, host cell protein quantitation, residual Protein A detection, and kinetic analyses. The system must meet specific technical requirements, including label-free, fluidics-free, real-time detection capabilities, and the ability to measure protein affinity, size, and kinetics. The contractor shall provide installation, operational qualification, on-site software walkthrough, and warranty for at least one year. The period of performance shall be one year from the date of delivery and installation of the instrument. Key features of the system include: • Label-free, fluidics-free, real-time detection capabilities • Ability to measure protein affinity, size, and kinetics • Analyze up to 96 samples simultaneously • Accurate quantitation of target protein in crude samples • Non-destructive sample analysis allowing for sample recovery The FDA requires the system to be delivered with specific accessories, including Protein A Biosensors, Host Cell Protein Detection Kit, High-Precision Streptavidin (SAX) Biosensors, and Evaporation Covers. The contractor must also provide on-site installation, calibration, and training.